CTRI/2022/09/045260尚未招募不适用
Primary Objective: To evaluate the in-vivo efficacy and safety of Skin care formulation in terms of tan reduction, reduction in pigmentation and skin smoothness on healthy male and female subjects.Secondary Objective: To evaluate the in-vivo efficacy and safety of Skin care formulation in terms of Skin brightness and Skin even tone on healthy male and female subjects.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- SkinQ
- 入组人数
- 36
- 试验地点
- 1
- 主要终点
- Tan reduction,
研究概览
简要总结
Objective:
Primary Objective: To evaluate the in-vivo efficacyand safety of Skin care formulation in terms of tan reduction, reduction inpigmentation and skin smoothness on healthy male and female subject.
Secondary Objective: To evaluate the in-vivo efficacyand safety of Skin care formulation in terms of Skin brightness and Skin eventone on healthy male and female subject.
Duration of study: 28 days study
Kinetics: T0, T+14 days and T+28 days
Population: 36 (Male & Female) volunteers
The evaluation is performed using:
1 Subject’sSelf Evaluation,
2 DermatologicalEvaluation: Cosmetic Acceptability,
3 DermatologicalEvaluation: Efficacy
4 Chromametry
5 Mexametry
6 IllustrativeImages of the whole face under diffuse light
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 45.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Indian male & female subjects.
- •2.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup).
- •3.Between 18 and 45 years of age.
- •4.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….).
- •6.Having uneven skin tone with pigmentation (Acne PIH / Melasma).
排除标准
- •1.For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2.For Male: Shave beard 1day prior before visit 3.Having refused to give his/her assent by not signing the consent form 4.Taking part in another study liable to interfere with this study 5.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 6.Having acne prone skin. 7.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 8.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products. 9.Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). 10.Having cutaneous hypersensitivity. 11.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 12.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 13.Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit. 14.Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted) 15.Refusing to follow the restrictions below during the study: For Females: Do not take part in any family planning activities leading to pregnancy and breastfeeding. Do not take part in another study liable to interfere with this study. Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). Do not change their cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit During the study: Do not use other cosmetic products than the tested products to the studied areas. The day of the measurements: No test product must be used (only face cleaned with water is accepted) 16.Having started, changed or interrupted one hormonal treatment (hormonal contraception, Hormone Replacement Therapy) during the past 3 months. 17.Having started, changed or stopped her tobacco consumption (for smokers consuming more than 10 cigarettes per day) in the previous 6 months. 18.Having consumed caffeine-based products (coffee, cola, tea, …), alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements 19.Having taken a medicinal treatment which could lead to hyper pigmentation (phenytoïn, amiodarone, metals, minocycline…) in the previous 6 months 20.Taking oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta carotene…) 21.Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask …) or having applied self-tanning products in the week preceding the start of the study 22.Having applied products with a depigmenting/ whitening action (hydroquinone or derivates…) in the 4 weeks preceding the start of the study. 23.Having undergone physical and/or chemical treatments of the spots (liquid nitrogen, dry ice, pulsed flash lamp, dermabrasion, chemical peel …) in the previous 6 months 24.Having a suntanned skin on the studied areas which could interfere with the evaluations of the study. 25.Refusing to follow the restrictions below during the study:.
- •Do not start, change or stop a hormonal treatment (hormonal contraception, Hormone Replacement Therapy).
- •Do not start a medicinal treatment which could lead to hyper pigmentation.
- •Do not take oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta-carotene…).
- •Do not consume caffeine-based products (coffee, cola, tea), alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements.
- •Do not have beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask …) or apply self tanning products.
- •Do not use products or techniques or surgery with a depigmenting / whitening action.
- •Do not expose herself to the sun by respecting a strict photo-protection.
结局指标
主要结局
Tan reduction,
时间窗: Baseline, Day14, Day28
reduction in pigmentation and skin smoothness
时间窗: Baseline, Day14, Day28
次要结局
- Skin brightness and(Skin even tone)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Evaluation of Safety and Efficacy of ProductCTRI/2022/05/042724Kama Ayurveda Pvt Ltd36
已完成
不适用
Safety and efficacy assessment of Product on skinCTRI/2023/03/050915DPKA UNIVERSAL CONSUMER VENTURES PRIVATE LIMITED50
尚未招募
不适用
Safety and efficacy assessment of Product on skinCTRI/2022/09/045182Kama Ayurveda Pvt Ltd40
已完成
不适用
Safety and Efficacy assessment of Cosmetic Product on skinCTRI/2023/02/049645Ajanta Pharma Ltd36
尚未招募
不适用
Safety and efficacy of skin care formulationCTRI/2021/08/035607Kama Ayurveda Pvt Ltd72